Want to join the conversation?
$ALXN received FDA approval for Strensiq (asfotase alfa) to treat patients with perinatal-, infantile- and juvenile-onset hypophosphatasia (HPP). HPP is genetic, chronic, and progressive ultra-rare metabolic disease that devastate effects on multiple systems of body, leading to debilitating or life-threatening complications.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.